Shuchen Lin
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Cells and Metastasis
Papers in
-
- Circular RNAs in diseases 2
- RNA modifications and cancer 2
-
- Cancer-related molecular mechanisms research 3
- Protease and Inhibitor Mechanisms 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Daliu Min (12 shared papers)Zhihua Gan (11 shared papers)Kun Han (9 shared papers)Yuh‐Shan Jou (2 shared papers)Chin‐Fu Hsiao (1 shared paper)Chen‐Tu Wu (1 shared paper)Yung-Chie Lee (1 shared paper)Yih‐Leong Chang (1 shared paper)
- Journals
- OncoTargets and Therapy (3 papers)BMC Cancer (2 papers)The Breast (2 papers)Cancer Letters (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Shuchen Lin
26 papers receiving 504 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 139
- Oncology 121
- Pulmonary and Respiratory Medicine 128
- Applied Microbiology and Biotechnology 6
- Molecular Biology 218
Countries citing papers authored by Shuchen Lin
This map shows the geographic impact of Shuchen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuchen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuchen Lin more than expected).
Fields of papers citing papers by Shuchen Lin
This network shows the impact of papers produced by Shuchen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuchen Lin. The network helps show where Shuchen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuchen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 95 | |
| 2 | 2016 | 62 | |
| 3 | 2016 | 49 | |
| 4 | 2011 | 40 | |
| 5 | 2022 | 37 | |
| 6 | 2015 | 32 | |
| 7 | 2017 | 29 | |
| 8 | 2017 | 23 | |
| 9 | 2016 | 19 | |
| 10 | 2019 | 17 | |
| 11 | 2014 | 14 | |
| 12 | 2020 | 10 | |
| 13 | 2015 | 9 | |
| 14 | 2021 | 8 | |
| 15 | Prognostic value of SOX2 in digestive tumors: a meta-analysis. | 2014 | 8 |
| 16 | 2020 | 7 | |
| 17 | 2017 | 7 | |
| 18 | 1970 | 6 | |
| 19 | 2016 | 6 | |
| 20 | 2015 | 6 |
About Shuchen Lin
Shuchen Lin is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 26 papers that have together received 507 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Circular RNAs in diseases (2 papers), Cancer Cells and Metastasis (2 papers), Protease and Inhibitor Mechanisms (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (139 citations), Oncology (121 citations), Pulmonary and Respiratory Medicine (128 citations), Applied Microbiology and Biotechnology (6 citations) and Molecular Biology (218 citations). Shuchen Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Daliu Min, Zhihua Gan, Kun Han, Yuh‐Shan Jou, Chin‐Fu Hsiao, Chen‐Tu Wu, Yung-Chie Lee, Yih‐Leong Chang, Yan Zhou and Yang Yao. Their work appears in journals such as OncoTargets and Therapy, BMC Cancer, The Breast, Cancer Letters and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.